Freeman-Sheldon syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Myosin heavy chain mutations that cause Freeman-Sheldon syndrome lead to muscle structural and functional defects in Drosophila.
|
30826400 |
2019 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Recessive Spondylocarpotarsal Synostosis Syndrome Due to Compound Heterozygosity for Variants in MYH3.
|
29805041 |
2018 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
MYH3 plays a pivotal role in fetal muscle development and mutations in this gene are associated with Freeman-Sheldon syndrome, distal arthrogryposis 8 (DA8), and autosomal dominant spondylocarpotarsal synostosis.
|
29314551 |
2018 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
To the best of our knowledge, this is the first report in the medical literature of molecularly confirmed parental mosaicism for a MYH3 mutation causing FSS.
|
26996280 |
2016 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Next generation sequencing in a large cohort of patients presenting with neuromuscular disease before or at birth.
|
26578207 |
2015 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Freeman-Sheldon syndrome, or distal arthrogryposis type 2A (DA2A), is an autosomal-dominant condition caused by mutations in MYH3 and characterized by multiple congenital contractures of the face and limbs and normal cognitive development.
|
25683120 |
2015 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
We measured the contractile properties of individual skeletal muscle cells and the activation and relaxation kinetics of isolated myofibrils from two adult individuals with an R672C substitution in embryonic myosin and distal arthrogryposis syndrome 2A (DA2A) or Freeman-Sheldon syndrome.
|
25740846 |
2015 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
DA type 2A (DA2A or Freeman-Sheldon syndrome), caused by mutations in MYH3, is typically considered the most severe of the DA syndromes.
|
25256237 |
2014 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Mutations in sarcomeric protein genes, including troponin I2 (TNNI2), troponin T3 (TNNT3), tropomyosin 2 (TPM2), embryonic myosin heavy chain 3 (MYH3), and myosin binding protein C1 (MYBPC1), have been identified in distal arthrogryposis type 1 (DA1, MIM 108120), type 2B (DA2B, MIM 601680) and type 2A (DA2A)/Freeman-Sheldon syndrome (FSS, MIM 193700).
|
23850728 |
2013 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Considering only genes that contained variants in all cases, the VEST gene score ranked dihydroorotate dehydrogenase (DHODH) number 2 of 2253 genes in four cases of Miller syndrome, and myosin-3 (MYH3) number 2 of 2313 genes in three cases of Freeman Sheldon syndrome.
|
23819870 |
2013 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
p.R672C mutation of MYH3 gene in an Egyptian infant presented with Freeman-Sheldon syndrome.
|
20924721 |
2011 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
DA2B, or Sheldon-Hall syndrome (SHS; MIM 601680), is intermediate to DA1 and DA2A, or Freeman-Sheldon syndrome (FSS; MIM193700), and shows prominent facial traits.
|
21402185 |
2011 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Identification of an MYH3 mutation in this family with distal arthrogryposis type 1 broadens the phenotype associated with MYH3 mutations to include distal arthrogryposis types 1, 2A (Freeman-Sheldon syndrome), and 2B (Sheldon-Hall syndrome).
|
21531865 |
2011 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Recently, mutations in skeletal muscle contractile genes MYH3 (myosin heavy chain 3), TNNT3 (troponin T3), and TPM2 (tropomyosin 2) were identified in patients with distal arthrogryposis DA2A (Freeman-Sheldon syndrome) or DA2B (Sheldon-Hall syndrome).
|
19142688 |
2009 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Embryonic myosin heavy-chain mutations cause distal arthrogryposis and developmental myosin myopathy that persists postnatally.
|
18695058 |
2008 |
Freeman-Sheldon syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
Embryonic myosin heavy-chain mutations cause distal arthrogryposis and developmental myosin myopathy that persists postnatally.
|
18695058 |
2008 |
Freeman-Sheldon syndrome
|
0.800 |
GermlineCausalMutation
|
disease |
ORPHANET |
FSS and SHS mutations affect different myosin residues, demonstrating that MYH3 genotype is predictive of phenotype.
|
16642020 |
2006 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
BEFREE |
Here we show that mutations in the embryonic myosin heavy chain (MYH3) gene cause Freeman-Sheldon syndrome (FSS), one of the most severe multiple congenital contracture (that is, arthrogryposis) syndromes, and nearly one-third of all cases of Sheldon-Hall syndrome (SHS), the most common distal arthrogryposis.
|
16642020 |
2006 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
FSS and SHS mutations affect different myosin residues, demonstrating that MYH3 genotype is predictive of phenotype.
|
16642020 |
2006 |
Freeman-Sheldon syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
FSS and SHS mutations affect different myosin residues, demonstrating that MYH3 genotype is predictive of phenotype.
|
16642020 |
2006 |
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We recently have characterized a new disorder (DA2B) with a phenotype intermediate between DA1 and FSS.
|
9012416 |
1997 |
Freeman-Sheldon syndrome
|
0.800 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Freeman-Sheldon syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|